etidronate has been researched along with Agnogenic Myeloid Metaplasia in 1 studies
Etidronic Acid: A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
etidronic acid : A 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with etidronate at a dose of 6 mg/kg per day on alternate months resulted in a complete recovery of bone symptoms and normalization of metabolic parameters of bone turnover; unexpectedly, a sustained haematological improvement was also observed after several months of therapy, suggesting that bone marrow microenvironment improvement was able to restore a nearly normal haemopoiesis." | 5.29 | Clinical and haematological improvement induced by etidronate in a patient with idiopathic myelofibrosis and osteosclerosis. ( Camaschella, C; Cesano, L; Guerrasio, A; Mazza, U; Sivera, P, 1994) |
| "Treatment with etidronate at a dose of 6 mg/kg per day on alternate months resulted in a complete recovery of bone symptoms and normalization of metabolic parameters of bone turnover; unexpectedly, a sustained haematological improvement was also observed after several months of therapy, suggesting that bone marrow microenvironment improvement was able to restore a nearly normal haemopoiesis." | 1.29 | Clinical and haematological improvement induced by etidronate in a patient with idiopathic myelofibrosis and osteosclerosis. ( Camaschella, C; Cesano, L; Guerrasio, A; Mazza, U; Sivera, P, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sivera, P | 1 |
| Cesano, L | 1 |
| Guerrasio, A | 1 |
| Camaschella, C | 1 |
| Mazza, U | 1 |
1 other study available for etidronate and Agnogenic Myeloid Metaplasia
| Article | Year |
|---|---|
Clinical and haematological improvement induced by etidronate in a patient with idiopathic myelofibrosis and osteosclerosis.
Topics: Aged; Etidronic Acid; Follow-Up Studies; Humans; Male; Osteosclerosis; Primary Myelofibrosis | 1994 |